Department of Radiation Oncology, University of Western Ontario, London, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.
Support Care Cancer. 2024 May 24;32(6):381. doi: 10.1007/s00520-024-08584-2.
Patients with lung cancer can experience significant psychological morbidities including depression. We characterize patterns and factors associated with interventions for symptoms of depression in stage IV non-small cell lung cancer (NSCLC).
We conducted a population-based cohort study using health services administrative data in Ontario, Canada of stage IV NSCLC diagnosed from January 2007 to September 2018. A positive symptom of depression score was defined by reporting at least one ESAS (Edmonton Symptom Assessment System) depression score ≥ 2 following diagnosis until the end of follow-up (September 2019). Patient factors included age, sex, comorbidity burden, rurality of residence, and neighbourhood income quintile. Interventions included psychiatry assessment, psychology referral, social work referral and anti-depressant medical therapy (for patients ≥ 65 years with universal drug coverage). Multivariable modified Poisson regression models were used to examine the association between patient factors and intervention use for patients who reported symptoms of depression.
In the cohort of 13,159 patients with stage IV NSCLC lung cancer, symptoms of depression were prevalent (71.4%, n = 9,397). Patients who reported symptoms of depression were more likely to receive psychiatry assessment/psychology referral (7.8% vs 3.5%; SD [standardized difference] 0.19), social work referral (17.4% vs 11.9%; SD 0.16) and anti-depressant prescriptions (23.8% vs 13.8%; SD 0.26) when compared to patients who did not report symptoms of depression respectively. In multivariable analyses, older patients were less likely to receive any intervention. Females were more likely to obtain a psychiatry assessment/psychology referral or social work referral. In addition, patients from non-major urban or rural residences were less likely to receive psychiatry assessment/psychology referral or social work referral, however patients from rural residences were more likely to be prescribed anti-depressants.
There is high prevalence of symptoms of depression in stage IV NSCLC. We identify patient populations, including older patients and rural patients, who are less likely to receive interventions that will help identifying and screening for symptoms of depression.
肺癌患者可能会经历严重的心理病态,包括抑郁。我们描述了与 IV 期非小细胞肺癌(NSCLC)中抑郁症状相关的干预模式和因素。
我们在加拿大安大略省进行了一项基于人群的队列研究,使用健康服务管理数据对 2007 年 1 月至 2018 年 9 月期间诊断的 IV 期 NSCLC 患者进行研究。在确诊后直至随访结束(2019 年 9 月),至少有一次 ESAS(埃德蒙顿症状评估系统)抑郁评分≥2 被定义为有阳性抑郁症状评分。患者因素包括年龄、性别、合并症负担、居住的农村程度和邻里收入五分位数。干预措施包括精神病评估、心理转介、社会工作转介和抗抑郁药物治疗(65 岁以上患者可获得全民药物覆盖)。多变量修正泊松回归模型用于检查报告有抑郁症状的患者中,患者因素与干预措施使用之间的关联。
在 13159 名 IV 期 NSCLC 肺癌患者中,抑郁症状普遍存在(71.4%,n=9397)。与未报告抑郁症状的患者相比,报告有抑郁症状的患者更有可能接受精神病评估/心理转介(7.8%比 3.5%;标准化差异 [SD] 0.19)、社会工作转介(17.4%比 11.9%;SD 0.16)和抗抑郁药物处方(23.8%比 13.8%;SD 0.26)。在多变量分析中,年龄较大的患者不太可能接受任何干预措施。女性更有可能接受精神病评估/心理转介或社会工作转介。此外,非主要城市或农村地区的患者不太可能接受精神病评估/心理转介或社会工作转介,但农村地区的患者更有可能开抗抑郁药。
IV 期 NSCLC 中抑郁症状的患病率很高。我们确定了一些患者人群,包括老年患者和农村患者,他们不太可能接受有助于识别和筛查抑郁症状的干预措施。